Nanion Technologies GmbH is a privately owned biotechnology company with a growing portfolio of in-house developed analytical instruments for electrophysiological research and drug development. See below for "then and now pictures" of our Port-a-Patch and Patchliner and our major milestones over the years.

Nanion has been recognized for its innovation over the years winning the "Bayerischer Innovationspreis" in 2006, winning the "Deutscher Gründerpreis" and German STEP awards in 2009, and being nominated twice for the "Deutscher Zukunftspreis". We have a close relationship with our customers, collaborators and partners, adapting and improving our instruments to meet their needs.

Milestones

Situated in the heart of Munich, we are a vibrant team of scientists and engineers with the goal of providing top quality instrumentation and customer service for a broad range of analytical applications. Since we were founded in 2002, Nanion has grown to one of the most respected automated patch clamp providers worldwide. With a focus on ion channels, we are committed to providing our customers with state-of-the-art technological solutions for all aspects of ion channel, transporter research and drug discovery, and we have expanded our product range to include extracellular recording techniques.

Through our employees we have a wealth of ion channel and electrophysiological expertise and base our technological developments on the needs of our academic and industrial customers. At our headquarters, engineers, scientists, and software developers work closely together under one roof to produce, assemble, improve and test every one of our devices and every batch of consumables that leaves the premises, so that you can be sure of the very best quality. We are a privately owned company, and our profit goes back into development of new and improved products.

We are proud to have been awarded multiple prestigious prizes over the years! Check out some highlights below.

As one of the leading industrial nations, Germany is known for its strength in technical innovation and entrepreneurship with a strong focus on product quality.

The Deutscher Zukunftspreis (German Future Award), by which the German Federal President rewards cutting-edge technological innovations, which also have a high potential for commercial success and societal benefit, is the country's most prestigious award for technology and innovation. The team has been nominated for the SyncroPatch 384/768PE, which enabled completely new strategies in drug discovery and scientific research from it´s launch date on. Find out more here.

Our new SyncroPatch 384 is a revolutionary automated patch clamp system consisting of a patch clamp module integrated into the state-of-the-art pipetting robot Biomek i5. With 384 amplifier channels and a 384-pipetting head, all 384 cells are recorded in parallel, resulting in a throughput of 20,000 data points per day. With its ease-of-use and open design, the SyncroPatch 384 supports full automation and integration into HTS environments.

SelectScience Scientists' Choice Awards Nomination

From biophysical characterization of Nobel Prize winning ion channels important in touch and temperature sensation, to routine safety testing of cardiac ion channels, the SyncroPatch 384 can do it all due to its high flexibility. The SyncroPatch 384 is an automated patch clamp device applicable to all aspects of ion channel drug discovery. We are delighted that the SyncroPatch 384 has been shortlisted for Best New Drug Discovery and Development Product of 2021!

Click here to vote for your favorite Drug Discovery product today

Over the 20 years, Nanion has grown to a company with more than 100 employees worldwide, at the beginning offering just one product, the Port-a-Patch, which now has increased to nine product families for all aspects of ion channel research and drug discovery, safety pharmacology, bilayer measurements and transporter research. We are proud to have daughter companies in Japan, the US and China, and a worldwide distributor network.